Selective GHS Peptide Overview
Ipamorelin is a synthetically engineered pentapeptide widely utilized in in vitro research focused on growth hormone secretagogue (GHS) activity. Its defined amino acid sequence supports targeted studies of endocrine signaling with high experimental specificity.
Receptor Selectivity Profile
In laboratory models, Ipamorelin has been characterized for its selective affinity to ghrelin (GHS-R) receptors. Research emphasizes its ability to stimulate growth hormone–related pathways without measurable interaction with cortisol-, prolactin-, or ACTH-associated signaling in controlled systems.
Stability & Laboratory Performance
Supplied as a white to off-white lyophilized powder, IPAMOR demonstrates reliable stability under recommended storage conditions. It readily reconstitutes in compatible solvents, supporting reproducibility across cellular and biochemical assays.
Pharmaceutical-Grade Manufacturing
Manufactured in the United States under GMP-compliant, pharmaceutical-grade conditions, each production lot is independently evaluated by certified third-party laboratories. Quality verification includes identity confirmation, purity assessment, sterility, and endotoxin screening.
Technical Specifications
-
Sequence: Aib-His-D-2-Nal-D-Phe-Lys-NH₂
-
Molecular Formula: C38H49N9O5
-
Molecular Weight: 711.85 g/mol
-
CAS Number: 170851-70-4
-
PubChem CID: 9831659
-
Synonyms: NNC-26-0161, Growth Hormone Releasing Peptide
-
Purity: ≥99% (HPLC)
-
Solubility: Soluble in water and DMSO
-
Form: White to off-white lyophilized powder
-
Storage: −20°C, tightly sealed, protected from heat and moisture
-
Shelf Life: 24–36 months when stored properly
Research Use Designation
IPAMOR is supplied strictly for in vitro research use only (RUO). It is not intended for human or animal consumption, clinical use, diagnostics, or therapeutic development.
